Harmonization across programmed death ligand 1 (PD‐L1) assays for lung cancer by immunohistochemistry using noncontact alternating current electric field mixing

Harmonization across programmed death ligand 1 (PD‐L1) assays for lung cancer by immunohistochemistry using noncontact alternating current electric field mixing

Abstract Background Immune checkpoint inhibitors (ICIs) are a promising advance in the treatment of patients with lung cancer. However, each ICI has been tested with an independently designed companion diagnostic assay that is based on a unique antibody. Consequently, the different trial‐validated p...

Full description

Bibliographic Details
Main Authors: Tsubasa Matsuo, Kazuhiro Imai, Hiroshi Nanjo, Shinogu Takashima, Yuko Hiroshima, Maiko Atari, Shoji Kuriyama, Yoshiaki Ishii, Yuki Wakamatsu, Yusuke Sato, Satoru Motoyama, Yuki Matsumura, Hiroyuki Suzuki, Kyoko Nomura, Yoshihiro Minamiya
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Thoracic Cancer
Subjects:
immune checkpoint inhibitor
immunohistochemistry
lung cancer
noncontact alternating current electric field mixing
PD‐L1
Online Access:https://doi.org/10.1111/1759-7714.13893

Internet

https://doi.org/10.1111/1759-7714.13893

Similar Items